{"cluster": 22, "subcluster": 12, "abstract_summ": "Funding This independent researcher-initiated study acknowledges financial support from the Antwerp University Fund, the Flemish Research Fund, and European Horizon 2020.Background: Covid-19 seroprevalence rates and serological tests are important tools in understanding the epidemiology of the disease and help in the fight against it.The point-of-care test to detect SARS-CoV-2 specific IgG antibody in peripheral blood (n =202) was performed in two community clinics in Tokyo, Japan.Background The seroprevalence of immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be a more reliable approach to detect true infected population, particularly in asymptomatic persons.All tested specimens were negative yielding a zero seroprevalence rate in this healthy blood donor population.In the ELISA test, IgG antibodies were positive in one serum sample, IgA antibodies were positive in 11, and borderline in 3 serum samples.", "title_summ": "Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China.[Screening of Mothers in a COVID-19 Low-Prevalence Region: Determination of SARS-CoV-2 Antibodies in 401 Mothers from Rostock by ELISA and Confirmation by Immunofluorescence].Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium: a prospective cross-sectional study of residual samplesCovid-19 Seroprevalence rate in healthy blood donors from a community under strict lockdown measuresRegional Difference in Seroprevalence of SARS-CoV-2 in Tokyo: Results from the community point-of-care antibody testingPreliminary Results of Seroprevalence of SARS-CoV-2 at Community Clinics in TokyoSeroprevalence and epidemiological characteristics of immunoglobulin M and G antibodies against SARS-CoV-2 in asymptomatic people in Wuhan, China", "title_abstract_phrases": "Preliminary Results of Seroprevalence of SARS-CoV-2 at Community Clinics in TokyoSerological evaluation with SARS-CoV-2 specific IgG antibody will be an alternative way to know the pandemic of novel coronavirus disease (COVID-19) if the capacity for diagnostic PCR test is limited.Funding This independent researcher-initiated study acknowledges financial support from the Antwerp University Fund, the Flemish Research Fund, and European Horizon 2020.Covid-19 Seroprevalence rate in healthy blood donors from a community under strict lockdown measuresBackground: Covid-19 seroprevalence rates and serological tests are important tools in understanding the epidemiology of the disease and help in the fight against it.Seroprevalence and epidemiological characteristics of immunoglobulin M and G antibodies against SARS-CoV-2 in asymptomatic people in Wuhan, ChinaBackground The seroprevalence of immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be a more reliable approach to detect true infected population, particularly in asymptomatic persons.The point-of-care test to detect SARS-CoV-2 specific IgG antibody in peripheral blood (n =202) was performed in two community clinics in Tokyo, Japan.More studies are needed to determine whether these results are generalizable to other populations and geographic locations, as well as to determine at what rate seroprevalence is increasing with the progress of the COVID-19 pandemic."}